Incyte Corporation (INCY)
USD 59.22
(4.13%)
USD 59.22
(4.13%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.44 Billion USD | 7.94% |
| 2022 | 3.18 Billion USD | 12.43% |
| 2021 | 2.83 Billion USD | 11.83% |
| 2020 | 2.53 Billion USD | 24.01% |
| 2019 | 2.04 Billion USD | 14.36% |
| 2018 | 1.78 Billion USD | 22.72% |
| 2017 | 1.45 Billion USD | 39.06% |
| 2016 | 1.04 Billion USD | 44.13% |
| 2015 | 726.77 Million USD | 42.93% |
| 2014 | 508.49 Million USD | 43.51% |
| 2013 | 354.31 Million USD | 19.34% |
| 2012 | 296.9 Million USD | 214.33% |
| 2011 | 94.45 Million USD | -44.4% |
| 2010 | 169.87 Million USD | 1733.55% |
| 2009 | 9.26 Million USD | 136.41% |
| 2008 | 3.91 Million USD | -88.62% |
| 2007 | 34.44 Million USD | 24.59% |
| 2006 | 27.64 Million USD | 252.32% |
| 2005 | 7.84 Million USD | -44.54% |
| 2004 | 14.14 Million USD | -69.96% |
| 2003 | 47.09 Million USD | -53.66% |
| 2002 | 101.61 Million USD | -53.66% |
| 2001 | 219.26 Million USD | -4.26% |
| 2000 | 229 Million USD | 26.04% |
| 1999 | 181.7 Million USD | 19.07% |
| 1998 | 152.6 Million USD | 54.45% |
| 1997 | 98.8 Million USD | 104.55% |
| 1996 | 48.3 Million USD | 226.35% |
| 1995 | 14.8 Million USD | 1245.45% |
| 1994 | 1.1 Million USD | 133.33% |
| 1993 | -3.3 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 950.77 Million USD | 15.96% |
| 2024 Q3 | 1.05 Billion USD | 10.63% |
| 2024 Q1 | 819.88 Million USD | -13.11% |
| 2023 Q1 | 751.85 Million USD | -13.33% |
| 2023 FY | 3.44 Billion USD | 7.94% |
| 2023 Q4 | 943.54 Million USD | 9.85% |
| 2023 Q2 | 886.31 Million USD | 17.88% |
| 2023 Q3 | 858.93 Million USD | -3.09% |
| 2022 FY | 3.18 Billion USD | 12.43% |
| 2022 Q1 | 690.62 Million USD | -15.67% |
| 2022 Q2 | 860.76 Million USD | 24.64% |
| 2022 Q3 | 768.7 Million USD | -10.69% |
| 2022 Q4 | 867.53 Million USD | 12.86% |
| 2021 FY | 2.83 Billion USD | 11.83% |
| 2021 Q4 | 818.97 Million USD | 5.94% |
| 2021 Q2 | 667.7 Million USD | 16.02% |
| 2021 Q3 | 773.08 Million USD | 15.78% |
| 2021 Q1 | 575.49 Million USD | -23.59% |
| 2020 Q4 | 753.18 Million USD | 28.45% |
| 2020 FY | 2.53 Billion USD | 24.01% |
| 2020 Q1 | 541.18 Million USD | -1.09% |
| 2020 Q2 | 654.64 Million USD | 20.96% |
| 2020 Q3 | 586.34 Million USD | -10.43% |
| 2019 Q1 | 475.26 Million USD | -5.33% |
| 2019 Q4 | 547.17 Million USD | 4.91% |
| 2019 FY | 2.04 Billion USD | 14.36% |
| 2019 Q3 | 521.54 Million USD | 4.2% |
| 2019 Q2 | 500.52 Million USD | 5.31% |
| 2018 Q4 | 502.03 Million USD | 18.16% |
| 2018 FY | 1.78 Billion USD | 22.72% |
| 2018 Q3 | 424.88 Million USD | -14.45% |
| 2018 Q1 | 364.17 Million USD | -13.66% |
| 2018 Q2 | 496.66 Million USD | 36.38% |
| 2017 FY | 1.45 Billion USD | 39.06% |
| 2017 Q1 | 369.25 Million USD | 20.32% |
| 2017 Q2 | 306.18 Million USD | -17.08% |
| 2017 Q3 | 359.49 Million USD | 17.41% |
| 2017 Q4 | 421.79 Million USD | 17.33% |
| 2016 Q3 | 249.26 Million USD | 6.56% |
| 2016 Q2 | 233.92 Million USD | -9.14% |
| 2016 FY | 1.04 Billion USD | 44.13% |
| 2016 Q4 | 306.88 Million USD | 23.12% |
| 2016 Q1 | 257.45 Million USD | 9.94% |
| 2015 Q4 | 234.17 Million USD | 30.41% |
| 2015 Q3 | 179.57 Million USD | 14.57% |
| 2015 Q1 | 156.3 Million USD | 28.6% |
| 2015 FY | 726.77 Million USD | 42.93% |
| 2015 Q2 | 156.73 Million USD | 0.27% |
| 2014 FY | 508.49 Million USD | 43.51% |
| 2014 Q4 | 121.54 Million USD | -38.59% |
| 2014 Q3 | 197.92 Million USD | 99.13% |
| 2014 Q2 | 99.39 Million USD | 10.9% |
| 2014 Q1 | 89.62 Million USD | -7.51% |
| 2013 FY | 354.31 Million USD | 19.34% |
| 2013 Q2 | 101.51 Million USD | 43.13% |
| 2013 Q1 | 70.92 Million USD | -37.64% |
| 2013 Q4 | 96.9 Million USD | 14.05% |
| 2013 Q3 | 84.96 Million USD | -16.3% |
| 2012 FY | 296.9 Million USD | 214.33% |
| 2012 Q2 | 86.52 Million USD | 139.23% |
| 2012 Q1 | 36.16 Million USD | 25.19% |
| 2012 Q4 | 113.74 Million USD | 88.13% |
| 2012 Q3 | 60.46 Million USD | -30.12% |
| 2011 Q3 | 16.78 Million USD | -0.17% |
| 2011 Q1 | 31.97 Million USD | -62.77% |
| 2011 Q4 | 28.89 Million USD | 72.15% |
| 2011 FY | 94.45 Million USD | -44.4% |
| 2011 Q2 | 16.81 Million USD | -47.42% |
| 2010 Q4 | 85.87 Million USD | 408.95% |
| 2010 Q2 | 49.84 Million USD | 188.33% |
| 2010 Q1 | 17.28 Million USD | 151.79% |
| 2010 FY | 169.87 Million USD | 1733.55% |
| 2010 Q3 | 16.87 Million USD | -66.15% |
| 2009 Q2 | 789 Thousand USD | 17.59% |
| 2009 Q4 | 6.86 Million USD | 631.2% |
| 2009 FY | 9.26 Million USD | 136.41% |
| 2009 Q1 | 671 Thousand USD | -28.46% |
| 2009 Q3 | 939 Thousand USD | 19.01% |
| 2008 FY | 3.91 Million USD | -88.62% |
| 2008 Q1 | 1.3 Million USD | -86.6% |
| 2008 Q2 | 614 Thousand USD | -53.02% |
| 2008 Q3 | 1.06 Million USD | 72.8% |
| 2008 Q4 | 938 Thousand USD | -11.59% |
| 2007 Q1 | 7.42 Million USD | 5.19% |
| 2007 Q4 | 9.75 Million USD | 45.77% |
| 2007 Q3 | 6.69 Million USD | -36.74% |
| 2007 Q2 | 10.57 Million USD | 42.5% |
| 2007 FY | 34.44 Million USD | 24.59% |
| 2006 Q2 | 6.85 Million USD | 6.03% |
| 2006 Q3 | 7.26 Million USD | 6.02% |
| 2006 FY | 27.64 Million USD | 252.32% |
| 2006 Q4 | 7.05 Million USD | -2.92% |
| 2006 Q1 | 6.46 Million USD | 528.89% |
| 2005 Q4 | 1.02 Million USD | -16.29% |
| 2005 FY | 7.84 Million USD | -44.54% |
| 2005 Q2 | 2.67 Million USD | -8.2% |
| 2005 Q1 | 2.91 Million USD | 377.09% |
| 2005 Q3 | 1.22 Million USD | -54.11% |
| 2004 Q2 | 5.16 Million USD | -22.26% |
| 2004 Q1 | 6.64 Million USD | -35.51% |
| 2004 FY | 14.14 Million USD | -69.96% |
| 2004 Q3 | 3.39 Million USD | -34.28% |
| 2004 Q4 | -1.05 Million USD | -131.01% |
| 2003 Q1 | 12.5 Million USD | -40.85% |
| 2003 FY | 47.09 Million USD | -53.66% |
| 2003 Q4 | 10.29 Million USD | -22.27% |
| 2003 Q3 | 13.24 Million USD | 20.05% |
| 2003 Q2 | 11.03 Million USD | -11.78% |
| 2002 Q3 | 22.39 Million USD | -22.95% |
| 2002 FY | 101.61 Million USD | -53.66% |
| 2002 Q4 | 21.14 Million USD | -5.54% |
| 2002 Q2 | 29.05 Million USD | 0.16% |
| 2002 Q1 | 29.01 Million USD | -47.03% |
| 2001 Q1 | 63.72 Million USD | -0.58% |
| 2001 Q2 | 56.05 Million USD | -12.04% |
| 2001 Q3 | 57.31 Million USD | 2.26% |
| 2001 Q4 | 54.77 Million USD | -4.44% |
| 2001 FY | 219.26 Million USD | -4.26% |
| 2000 Q1 | 48.86 Million USD | -7.97% |
| 2000 Q3 | 61.61 Million USD | 13.2% |
| 2000 Q4 | 64.09 Million USD | 4.02% |
| 2000 FY | 229 Million USD | 26.04% |
| 2000 Q2 | 54.43 Million USD | 11.38% |
| 1999 Q4 | 53.1 Million USD | 28.57% |
| 1999 Q3 | 41.3 Million USD | -6.77% |
| 1999 Q2 | 44.3 Million USD | 3.02% |
| 1999 FY | 181.7 Million USD | 19.07% |
| 1999 Q1 | 43 Million USD | 1.42% |
| 1998 Q2 | 37.1 Million USD | 8.8% |
| 1998 Q4 | 42.4 Million USD | 8.72% |
| 1998 Q3 | 39 Million USD | 5.12% |
| 1998 Q1 | 34.1 Million USD | 14.43% |
| 1998 FY | 152.6 Million USD | 54.45% |
| 1997 FY | 98.8 Million USD | 104.55% |
| 1997 Q1 | 20.1 Million USD | 22.56% |
| 1997 Q2 | 23.6 Million USD | 17.41% |
| 1997 Q3 | 25.4 Million USD | 7.63% |
| 1997 Q4 | 29.8 Million USD | 17.32% |
| 1996 Q2 | 8.9 Million USD | 34.85% |
| 1996 Q3 | 14.9 Million USD | 67.42% |
| 1996 Q4 | 16.4 Million USD | 10.07% |
| 1996 FY | 48.3 Million USD | 226.35% |
| 1996 Q1 | 6.6 Million USD | 13.79% |
| 1995 Q1 | 1.9 Million USD | 375.0% |
| 1995 Q4 | 5.8 Million USD | 65.71% |
| 1995 Q3 | 3.5 Million USD | 34.62% |
| 1995 Q2 | 2.6 Million USD | 36.84% |
| 1995 FY | 14.8 Million USD | 1245.45% |
| 1994 Q3 | 300 Thousand USD | 123.08% |
| 1994 Q2 | -1.3 Million USD | -1400.0% |
| 1994 FY | 1.1 Million USD | 133.33% |
| 1994 Q1 | 100 Thousand USD | 110.0% |
| 1994 Q4 | 400 Thousand USD | 33.33% |
| 1993 FY | -3.3 Million USD | 0.0% |
| 1993 Q3 | -800 Thousand USD | 0.0% |
| 1993 Q4 | -1 Million USD | -25.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | -2364.383% |
| Immix Biopharma, Inc. | -5468.00 USD | 62923454.06% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 518270.03% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 4533.94% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 652974.573% |
| MiMedx Group, Inc. | 266.84 Million USD | -1189.391% |
| Novavax, Inc. | 639.93 Million USD | -437.654% |
| Seer, Inc. | 7.02 Million USD | -48863.27% |
| Acelyrin, Inc. | -115 Thousand USD | 2991968.696% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -2443.561% |
| IO Biotech, Inc. | -756 Thousand USD | 455212.302% |
| Ardelyx, Inc. | 106.66 Million USD | -3125.78% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 3648.89% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 11139.164% |
| Fortress Biotech, Inc. | 57.85 Million USD | -5847.227% |
| Fortress Biotech, Inc. | 57.85 Million USD | -5847.227% |
| Geron Corporation | -123.5 Million USD | 2885.883% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -1329.227% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -20655.559% |
| Innoviva, Inc. | 261.06 Million USD | -1217.928% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 6255825.455% |
| ChromaDex Corporation | 50.78 Million USD | -6675.599% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -2773.121% |
| MEI Pharma, Inc. | 49.32 Million USD | -6875.184% |
| NextCure, Inc. | -3.68 Million USD | 93494.381% |
| Onconetix, Inc. | -1.12 Million USD | 305348.034% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 11977.413% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 2401094.41% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 3342.133% |
| Vaxcyte, Inc. | -75 Million USD | 4687.532% |
| Precigen, Inc. | 106 Thousand USD | -3245795.283% |
| Pharming Group N.V. | 220.1 Million USD | -1463.192% |
| ContextLogic Inc. | 59 Million USD | -5731.608% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 1483138.362% |
| Pyxis Oncology, Inc. | -2 Million USD | 172132.45% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -3034.359% |
| AlloVir, Inc. | -398 Thousand USD | 864584.673% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -11741.848% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 34232007.273% |
| Summit Therapeutics Inc. | -2.05 Million USD | 167936.537% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 28672175.0% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 602665.499% |
| Senti Biosciences, Inc. | -2.68 Million USD | 128338.874% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -2867107.5% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 71810.067% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -11711.765% |
| Psyence Biomedical Ltd. | -240.00 USD | 1433603850.0% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 7786487.707% |
| Chimerix, Inc. | 324 Thousand USD | -1061828.704% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 6001999.662% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 4196013.415% |
| CRISPR Therapeutics AG | 240.95 Million USD | -1327.916% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -3205.17% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -667987.184% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -340895.937% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 93292.01% |
| Precision BioSciences, Inc. | 40.47 Million USD | -8401.307% |
| Dyadic International, Inc. | 922.95 Thousand USD | -372685.406% |
| Elevation Oncology, Inc. | -39 Thousand USD | 8822276.923% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -16236.589% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -2755.927% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -126.674% |
| Aptorum Group Limited | -1.11 Million USD | 308764.756% |
| Bicycle Therapeutics plc | -129.52 Million USD | 2756.462% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 87380.748% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -43612.984% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 25857.51% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | -150.287% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -78489.516% |
| Jaguar Health, Inc. | 7.72 Million USD | -44444.912% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -693579.234% |
| AbCellera Biologics Inc. | 38.02 Million USD | -8948.387% |
| PureTech Health plc | -1.6 Million USD | 214738.116% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 665929.827% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 7691.062% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -428908.603% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -15869.594% |
| AnaptysBio, Inc. | 14.78 Million USD | -23177.512% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 15112.213% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 2903821.802% |
| Molecular Templates, Inc. | 50.39 Million USD | -6727.362% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -11608.065% |
| Vaxxinity, Inc. | -2.23 Million USD | 154112.936% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 699418.902% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 15748.561% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 7445.693% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 362588.753% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 68813080.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -84833.325% |
| ImmuCell Corporation | 4.39 Million USD | -78162.665% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1967950.586% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -811373.821% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -17967.789% |
| Opthea Limited | 21.72 Thousand USD | -15840825.414% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1996.636% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 3603.109% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 3605.037% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -564866.995% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -996.894% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -133569.347% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 6781040.087% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 48573.5% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 725141.671% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 33083263.462% |
| Soligenix, Inc. | 97.31 Thousand USD | -3535624.635% |
| Century Therapeutics, Inc. | -10.8 Million USD | 31931.335% |
| Kura Oncology, Inc. | -849 Thousand USD | 405359.011% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 5227.338% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 2340677.551% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -3374.034% |
| Autolus Therapeutics plc | -4.86 Million USD | 70793.425% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -8213.558% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 2048105.357% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -3532.327% |
| GRI Bio, Inc. | 10.84 Million USD | -31637.377% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -135359.369% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 39706.872% |
| IGM Biosciences, Inc. | -211.66 Million USD | 1725.555% |
| INmune Bio, Inc. | 155 Thousand USD | -2219673.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -5454.899% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 228518.612% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 530692.609% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 11753358.865% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -855782.836% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 172477.204% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 1099348.882% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -3542.402% |
| Verastem, Inc. | -62 Thousand USD | 5549533.871% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -141199.754% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 1318356.322% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -113565.312% |
| Histogen Inc. | 3.76 Million USD | -91188.114% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -597049.323% |
| Surrozen, Inc. | -27.23 Million USD | 12735.509% |
| Organovo Holdings, Inc. | -5.38 Million USD | 63945.778% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 285659.475% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 13515.405% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -17058.633% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 173770251.515% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -56616.273% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 5125375.953% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -2122.771% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -2359741.564% |
| Apollomics, Inc. | 127 Thousand USD | -2709072.441% |
| Amarin Corporation plc | 165.54 Million USD | -1978.427% |
| Mesoblast Limited | -9.81 Million USD | 35155.008% |
| Turnstone Biologics Corp. | 16.5 Million USD | -20744.838% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 3214.019% |
| Synaptogenix, Inc. | -6347.00 USD | 54209159.398% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 6746470.588% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -2032.215% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | -95.752% |
| Better Therapeutics, Inc. | -2.72 Million USD | 126177.281% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 3167.598% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -917.7% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 30160066.69% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 55062.444% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 310627.888% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -46916.241% |
| Insmed Incorporated | 239.63 Million USD | -1335.787% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -96061.235% |
| OmniAb, Inc. | 14.66 Million USD | -23358.437% |
| Alector, Inc. | -95.05 Million USD | 3719.716% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -2638.912% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 8016.271% |
| Zai Lab Limited | 170.9 Million USD | -1913.217% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -4102.217% |
| Aura Biosciences, Inc. | -1.29 Million USD | 265787.181% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -2646553.077% |
| Immunic, Inc. | -111 Thousand USD | 3099783.784% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -21602.088% |
| Veracyte, Inc. | 248.14 Million USD | -1286.531% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 149.229% |
| FibroGen, Inc. | 128.9 Million USD | -2569.156% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 610044248.936% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 29590.725% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | -1.236% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -884385.604% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -868.256% |
| TG Therapeutics, Inc. | 219.1 Million USD | -1470.298% |
| Galecto, Inc. | -830 Thousand USD | 414636.024% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 248522.31% |
| Fortrea Holdings Inc. | 424 Million USD | -711.474% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 4093.001% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 606916.402% |
| XBiotech Inc. | -1.74 Million USD | 197384.92% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 310627.888% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 7503.863% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 4655.1% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -4587.341% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -20376.397% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -784.395% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 7030.225% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -952.988% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 30484.113% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -13971.609% |
| NexImmune, Inc. | -1.02 Million USD | 335782.243% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -63715622.222% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 48521.272% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 69.556% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 5148691.138% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 96992.397% |
| Ainos, Inc. | -253.73 Thousand USD | 1356111.634% |
| Pluri Inc. | 322 Thousand USD | -1068424.534% |
| Prothena Corporation plc | -129.2 Million USD | 2763.02% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -6723.443% |
| Celularity Inc. | 6.75 Million USD | -50834.848% |
| Rallybio Corporation | -150 Thousand USD | 2293866.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 10651.872% |
| MeiraGTx Holdings plc | 287 Thousand USD | -1198732.404% |
| Omeros Corporation | -69.77 Million USD | 5030.78% |
| Humacyte, Inc. | -76.55 Million USD | 4594.643% |
| Immunocore Holdings plc | 248.39 Million USD | -1285.175% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 22782.108% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -5415.452% |
| Blueprint Medicines Corporation | 236.58 Million USD | -1354.303% |
| CalciMedica, Inc. | -58 Thousand USD | 5932253.448% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 241379.734% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 121079.219% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 11247.413% |
| Pulmatrix, Inc. | -8.22 Million USD | 41957.044% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 294172.564% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 862418.045% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 962.763% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -123861.219% |
| Cytokinetics, Incorporated | -322.59 Million USD | 1166.56% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -398998.602% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 1009087.977% |
| Vor Biopharma Inc. | -3.49 Million USD | 98629.467% |
| Roivant Sciences Ltd. | 109.23 Million USD | -3049.768% |
| Evogene Ltd. | 1.39 Million USD | -245836.312% |
| ProKidney Corp. | -3.16 Million USD | 108672.073% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 7935.327% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -50077.177% |
| CorMedix Inc. | -205.56 Thousand USD | 1673876.768% |
| BioLineRx Ltd. | 1.1 Million USD | -310427.888% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 4473.465% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 10426309.091% |
| Atai Life Sciences N.V. | -5000.00 USD | 68813080.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 2823567.286% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 3584109.375% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 247806.911% |
| Sagimet Biosciences Inc. | 2 Million USD | -171932.45% |
| MediciNova, Inc. | 979.7 Thousand USD | -351092.349% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 4180.514% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3638880.604% |
| GeoVax Labs, Inc. | -20.72 Million USD | 16704.835% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -1307.017% |
| Biomea Fusion, Inc. | -4.2 Million USD | 82000.714% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -294.418% |
| Mereo BioPharma Group plc | 7.42 Million USD | -46232.467% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 1109986.774% |
| Absci Corporation | -41.84 Million USD | 8321.58% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 68813080.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 4605.059% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 139906.948% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -1509.773% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 365737.513% |
| Allakos Inc. | -6.14 Million USD | 56127.504% |
| Imunon, Inc. | -720 Thousand USD | 477964.598% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 5086.737% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -622.986% |
| BioAtla, Inc. | -103.73 Million USD | 3416.896% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 30160066.69% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 1933048.876% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 1516.96% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 1106418.006% |
| XOMA Corporation | 3.86 Million USD | -89012.898% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 5009.252% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -23157.057% |
| aTyr Pharma, Inc. | -2.38 Million USD | 144180.779% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -27513.555% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 11864406.897% |
| Viridian Therapeutics, Inc. | -1 Million USD | 341434.226% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -26466530669.231% |
| Akari Therapeutics, Plc | -4000.00 USD | 86016325.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -440.225% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1766981.476% |
| UroGen Pharma Ltd. | 73.35 Million USD | -4590.6% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 12989.222% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -29635119.638% |
| Orgenesis Inc. | -5.72 Million USD | 60198.672% |
| Entera Bio Ltd. | -56 Thousand USD | 6144116.071% |
| GH Research PLC | -315 Thousand USD | 1092369.524% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1820549.206% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 655461.714% |
| Xencor, Inc. | -85.26 Million USD | 4135.479% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 1557116.794% |
| Replimune Group, Inc. | -2.65 Million USD | 129691.299% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 343740.161% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -1834.644% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1766981.476% |
| Portage Biotech Inc. | -54 Thousand USD | 6371672.222% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 3638880.604% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 912738.992% |
| OncoCyte Corporation | 413 Thousand USD | -832986.925% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 76544015.462% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 1549841991.892% |
| Purple Biotech Ltd. | -196 Thousand USD | 1755533.163% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -38265.845% |
| scPharmaceuticals Inc. | 9.78 Million USD | -35073.267% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 33040.767% |
| HilleVax, Inc. | -2.15 Million USD | 159684.833% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 3547160.825% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 22931644.921% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 515167.216% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 14959443.478% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 45837771.992% |
| Savara Inc. | -44.26 Million USD | 7873.37% |
| Curis, Inc. | 9.81 Million USD | -34969.3% |
| Daré Bioscience, Inc. | 2.76 Million USD | -124132.593% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 2757295.403% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 199096.472% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 1509156.579% |
| BeiGene, Ltd. | 2.07 Billion USD | -65.507% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 123160.517% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 960.885% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -5969.449% |
| Erasca, Inc. | -3.73 Million USD | 92293.167% |
| bluebird bio, Inc. | -4.03 Million USD | 85475.906% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 12193200.149% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -80.671% |
| DBV Technologies S.A. | 15.72 Million USD | -21775.947% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 12193200.149% |
| Moderna, Inc. | 2.15 Billion USD | -59.659% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 376127.213% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -42875.881% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 642012.127% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -2471.717% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 55398.12% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 8845.263% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 3196.113% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 95993.227% |
| MacroGenics, Inc. | 50.52 Million USD | -6709.526% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 56522.581% |
| Prime Medicine, Inc. | -147.9 Million USD | 2426.256% |
| Aditxt, Inc. | -111.66 Thousand USD | 3081462.171% |
| Adagene Inc. | 18.11 Million USD | -18897.05% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -704951.025% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -2354.066% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -2079.889% |
| SciSparc Ltd. | 2.19 Million USD | -156578.005% |
| Vericel Corporation | 135.57 Million USD | -2437.801% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 13735774.079% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 11105415.99% |
| Generation Bio Co. | -73.91 Million USD | 4755.124% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 787433.867% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -6199.363% |
| Invivyd, Inc. | -2.02 Million USD | 169757.249% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 1243.677% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 3326391.112% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -3470.323% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -3400.579% |
| ADMA Biologics, Inc. | 88.21 Million USD | -3800.167% |
| Clene Inc. | 533 Thousand USD | -645425.141% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -14171.113% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 359624.451% |
| GeoVax Labs, Inc. | -20.72 Million USD | 16704.835% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -172970.875% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1770746.267% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -6808.24% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 48614.509% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 411660.885% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -4024.737% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -4705897.647% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -6372.008% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 2086.656% |
| Trevena, Inc. | 1.45 Million USD | -236370.722% |
| Surrozen, Inc. | -27.23 Million USD | 12735.509% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 974788.102% |
| Cingulate Inc. | -582.91 Thousand USD | 590345.798% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 11098967.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 17566.11% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 45451209.643% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 390639.047% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -405.453% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 348343.826% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 6106821.451% |
| Kronos Bio, Inc. | 1.37 Million USD | -250676.166% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 6511.227% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 1178404.452% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 704697.656% |
| ImmunityBio, Inc. | -17.89 Million USD | 19332.247% |
| Korro Bio, Inc. | -3.63 Million USD | 94883.719% |
| Kineta, Inc. | 5.43 Million USD | -63228.713% |
| BioVie Inc. | -229.37 Thousand USD | 1500097.384% |
| Codexis, Inc. | 57.33 Million USD | -5901.062% |
| Celularity Inc. | 6.75 Million USD | -50834.848% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -85637.578% |
| Celcuity Inc. | -142.77 Thousand USD | 2409990.595% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -6800945.661% |
| Cibus, Inc. | 1.42 Million USD | -241858.439% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 920059.626% |
| IN8bio, Inc. | -2.5 Million USD | 137670.932% |
| Kodiak Sciences Inc. | -25.94 Million USD | 13360.296% |
| Annexon, Inc. | -3.26 Million USD | 105415.243% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 168429.207% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 8343.642% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -537501.406% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -341.951% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1889.332% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 181186.789% |
| Arcellx, Inc. | 108.27 Million USD | -3077.577% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 10729.457% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -4244.034% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 16366.306% |
| Moolec Science SA | -143.3 Thousand USD | 2401027.393% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 8230.462% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -104574.445% |
| Royalty Pharma plc | 1.79 Billion USD | -91.797% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 5008.901% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 95256163.123% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -1486841.584% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 3188.166% |
| Humacyte, Inc. | -76.55 Million USD | 4594.643% |
| 89bio, Inc. | -273 Thousand USD | 1260410.989% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 273819.093% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 405836.91% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 2797375.61% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -307375.335% |
| Notable Labs, Ltd. | 113 Thousand USD | -3044722.124% |
| Liquidia Corporation | 14.6 Million USD | -23466.089% |
| Mustang Bio, Inc. | -2.22 Million USD | 154735.91% |
| Immunovant, Inc. | -231 Thousand USD | 1489558.442% |
| Quantum-Si incorporated | 488 Thousand USD | -704951.025% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 6292.784% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 11468930.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -184682.438% |
| Acasti Pharma Inc. | -11 Thousand USD | 31278727.273% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1681606.913% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 530692.609% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 2153.972% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -303153.098% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 903157.48% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 175822.625% |
| PepGen Inc. | -1.18 Million USD | 290695.355% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 2709272.441% |
| United Therapeutics Corporation | 2.07 Billion USD | -66.215% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 15126.637% |
| Solid Biosciences Inc. | -76.56 Million USD | 4593.88% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 4166392.094% |
| Immuneering Corporation | -764.13 Thousand USD | 450365.397% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -5192235.205% |
| Belite Bio, Inc | -399 Thousand USD | 862418.045% |
| XOMA Corporation | 3.86 Million USD | -89012.898% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 17272.335% |
| Bionomics Limited | -434.44 Thousand USD | 792056.939% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 320458.38% |
| uniQure N.V. | 2.21 Million USD | -155234.041% |
| Cassava Sciences, Inc. | -89.42 Million USD | 3947.611% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 3837.033% |
| Forte Biosciences, Inc. | -9000.00 USD | 38229533.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 412153.772% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 787433.867% |
| Altimmune, Inc. | -65.37 Million USD | 5363.104% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -850.377% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 320458.38% |
| Compugen Ltd. | 31.45 Million USD | -10838.321% |
| Peak Bio, Inc. | 367.76 Thousand USD | -935446.226% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -13934.3% |
| Benitec Biopharma Inc. | 108 Thousand USD | -3185686.111% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 4411188.462% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 286105.736% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 188939.133% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 2891401.681% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 286105.736% |
| Instil Bio, Inc. | -4.75 Million USD | 72443.335% |
| argenx SE | 1.1 Billion USD | -210.393% |
| Immunome, Inc. | -8.9 Million USD | 38728.595% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 182144.921% |
| Verona Pharma plc | -679.62 Thousand USD | 506357.725% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1966185.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | 144362.013% |
| CervoMed Inc. | -1.29 Million USD | 266069.17% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 143043.457% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 72125.309% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -139141.157% |
| Moolec Science SA | -143.3 Thousand USD | 2401027.393% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 843334.321% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 128889.554% |
| Design Therapeutics, Inc. | -537 Thousand USD | 640816.76% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 805872.6% |
| NeurAxis, Inc. | 2.15 Million USD | -159432.741% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -160228.472% |
| Lumos Pharma, Inc. | 2 Million USD | -171332.436% |
| Achilles Therapeutics plc | -4.73 Million USD | 72821.514% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1966185.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 3255977.928% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -10767.923% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -398998.602% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 333496.221% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 7653.897% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -8001409.302% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 418670.438% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 26148823.21% |
| Palisade Bio, Inc. | 246 Thousand USD | -1398537.805% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 10426309.091% |
| Beam Therapeutics Inc. | -59.67 Million USD | 5865.935% |
| Neurogene Inc. | -3.26 Million USD | 105576.671% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -2369.336% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -8501.623% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 1158567.677% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 85538.723% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 36067.479% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -24336.428% |
| Athira Pharma, Inc. | -969 Thousand USD | 355172.136% |
| Vaccinex, Inc. | -16 Million USD | 21598.682% |
| HCW Biologics Inc. | -574.82 Thousand USD | 598656.95% |
| XOMA Corporation | 3.86 Million USD | -89012.898% |
| Nektar Therapeutics | 53.47 Million USD | -6333.765% |
| Arvinas, Inc. | 71.8 Million USD | -4691.99% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 4222.462% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 5580.922% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 1068624.534% |
| Rezolute, Inc. | -36 Thousand USD | 9557458.333% |
| Clene Inc. | 533 Thousand USD | -645425.141% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 267963417.757% |
| BeyondSpring Inc. | 1.75 Million USD | -196396.231% |
| Synlogic, Inc. | -1.92 Million USD | 178927.911% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 9299151.351% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 54437.476% |
| Peak Bio, Inc. | 367.76 Thousand USD | -935446.226% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 18244.012% |
| Krystal Biotech, Inc. | 47.6 Million USD | -7127.495% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -2338.603% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -68370.627% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 132983.661% |
| MannKind Corporation | 136.19 Million USD | -2426.341% |
| Ikena Oncology, Inc. | -50.49 Million USD | 6914.246% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -3061.954% |
| Gossamer Bio, Inc. | -4.38 Million USD | 78564.059% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 1365436.905% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 68813080.0% |
| Legend Biotech Corporation | 140.92 Million USD | -2341.406% |
| Mural Oncology plc | -2.56 Million USD | 134133.853% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 624537.205% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 3440749.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -16478.245% |
| REGENXBIO Inc. | 53.02 Million USD | -6388.24% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 64327.724% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1788611.501% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 198751.79% |
| Vaxart, Inc. | -60.76 Million USD | 5762.408% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 1309426.813% |
| Cellectis S.A. | 18 Thousand USD | -19114616.667% |
| Longeveron Inc. | 221 Thousand USD | -1556754.751% |
| Repare Therapeutics Inc. | -80.07 Million USD | 4397.051% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -214.791% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 265992.504% |
| Revolution Medicines, Inc. | -399.66 Million USD | 960.885% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 9830525.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -7021632.653% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 60.025% |
| Denali Therapeutics Inc. | -93.34 Million USD | 3785.949% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 13735774.079% |
| Veru Inc. | 7.56 Million USD | -45375.572% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 2278675.497% |
| Cingulate Inc. | -582.91 Thousand USD | 590345.798% |
| Passage Bio, Inc. | -3.72 Million USD | 92565.708% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 28567428.13% |
| Exicure, Inc. | -1.42 Million USD | 241888.405% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 898441.775% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -127190.011% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 671216.984% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -4950.42% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 2299891.454% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 5911.318% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -879861.381% |
| OmniAb, Inc. | 14.66 Million USD | -23358.437% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -17109.268% |
| Lipocine Inc. | -2.85 Million USD | 120789.886% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 186787.412% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 60409.36% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 228518.612% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -4468.284% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 5293406.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -3981.628% |
| Ocugen, Inc. | -33.53 Million USD | 10359.263% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 108912.429% |
| Q32 Bio Inc. | 578 Thousand USD | -595167.993% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 1298458.113% |
| Alumis Inc. Common Stock | -1.28 Million USD | 268063.318% |
| Equillium, Inc. | 35.95 Million USD | -9468.522% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 201661.16% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -687096.587% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 83228184.18% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 1328535.907% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -813846.375% |
| Dominari Holdings Inc. | 2.03 Million USD | -168641.981% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1875409.449% |
| vTv Therapeutics Inc. | -13.59 Million USD | 25408.194% |
| Bio-Techne Corporation | 773.07 Million USD | -345.061% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -19766.326% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -646.691% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 294424.123% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 14447.994% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -29314.799% |
| Nkarta, Inc. | -5.86 Million USD | 58724.11% |
| BioCardia, Inc. | -7.24 Million USD | 47563.774% |
| Iterum Therapeutics plc | -1.75 Million USD | 196708.514% |